| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 04/24/2003 | WO2002051988A3 Thymic epithelial progenitor cells and uses thereof |
| 04/24/2003 | WO2002012447A3 Isolation and use of solid tumor stem cells |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2001078796A3 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | US20030079242 Animal model for use as tool in diagnosing and treating tumors |
| 04/24/2003 | US20030079241 Isolation of precancerous tissue; obtain mammary gland tissue from cancer prone rodent, implant cells into nontrangenic rodent, detect propagation of cells, generate clonal series from propagating cells |
| 04/24/2003 | US20030079240 Chimeric embryos and animals containing human cells |
| 04/24/2003 | US20030079238 Polynucleotide encoding a human junctional adhesion protein (JAM-2) |
| 04/24/2003 | US20030079237 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 04/24/2003 | US20030079235 Assay for measuring enzyme activity in vivo |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030077750 Peptide for use in human therapeutics and diagnostics |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077706 Mouse cytokine receptor |
| 04/24/2003 | US20030077614 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/23/2003 | EP1304371A1 Cds1 GENE-KNOCKOUT CELLS AND MOUSE AND UTILIZATION THEREOF |
| 04/23/2003 | EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 04/23/2003 | EP1303609A2 G-protein coupled receptors |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303534A2 Promyostatin peptides and methods of using same |
| 04/23/2003 | EP1303301A2 Preventing airway mucus production by administration of egf-r antagonists |
| 04/23/2003 | EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 04/23/2003 | EP0961827A4 Mammalian and human rec2 |
| 04/23/2003 | CN1413230A Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/23/2003 | CN1412302A Method for preparing transfer mitochondrial genome mouse |
| 04/23/2003 | CN1411711A American large roach cultivation method |
| 04/23/2003 | CN1411710A Domestic animal and poultry cultivation method capable of preventing and curing chronic diseases of cancer and hepatitis B |
| 04/23/2003 | CN1411709A Nuisance-free green feeding technique for hog |
| 04/23/2003 | CN1411708A Artificial sucking-pig feeding technique without antibiotic medicine |
| 04/22/2003 | US6552246 Marker sequence has been substituted for at least intron 6 and exon 6, and wherein disruption prevents expression of CD45 on B-cells and T-cells and results in a decreased cytotoxic T-cell response |
| 04/22/2003 | US6551989 Preventing airway mucus production by administration of EGF-R antagonists |
| 04/22/2003 | US6551825 PiggyBac transposon-based genetic transformation system for insects |
| 04/22/2003 | US6551594 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method |
| 04/22/2003 | US6550419 Arthropod diet delivery system |
| 04/17/2003 | WO2003031940A2 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031629A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | WO2003031612A2 Method for determining cell cycle position |
| 04/17/2003 | WO2003031595A2 Molecules for disease detection and treatment |
| 04/17/2003 | WO2003031590A2 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | WO2003030922A2 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis |
| 04/17/2003 | WO2003030637A1 Feed for elevating viral infection ratio in silkworm and method of viral inoculation using the feed |
| 04/17/2003 | WO2003030636A1 Rodent with urinary disturbance and method of constructing the same, and method of screening remedy for urinary disturbance using the rodent |
| 04/17/2003 | WO2003030635A1 A herbal hepatoprotective and weight gain promoter and a process thereof |
| 04/17/2003 | WO2002094863A3 INTERFERON-α INDUCED GENE |
| 04/17/2003 | WO2002086064A3 Inducible expression of transfected genes |
| 04/17/2003 | WO2002085943A3 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof |
| 04/17/2003 | WO2002074965A3 Characterization of the i-spoml endonuclease from fission yeast |
| 04/17/2003 | WO2002070706A3 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/17/2003 | WO2002031168A3 Minimal adenoviral vector and recombinant vaccines based thereon |
| 04/17/2003 | WO2002024891A3 B7-like molecules and uses thereof |
| 04/17/2003 | WO2002020619A9 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 04/17/2003 | WO2002004511A3 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS |
| 04/17/2003 | WO1999063052A3 Bigenic mouse models and assays to identify proliferation and differentiation regulators |
| 04/17/2003 | US20030074684 Control of gene expression |
| 04/17/2003 | US20030074681 Replication defective retroviral vector for use as gene transfer tool in genetic engineering |
| 04/17/2003 | US20030074679 Administration of nucleic acid sequence to female animal to enhance growth in offspring |
| 04/17/2003 | US20030074676 I0nduction of preferential immunoglobulin in mammal; obtain mammal, immunize with tumor necrosis factor, monitor expression of immunoglobulin in milk |
| 04/17/2003 | US20030073659 Encapsulation of virus; genetic engineering; packaging signal |
| 04/17/2003 | US20030073080 Genetically engineered viral nucleotide sequences for use as tool in gene therapy and vaccine development |
| 04/17/2003 | US20030072787 Animal food and method |
| 04/17/2003 | CA2463453A1 Methods of preparing a targeting vector and uses thereof |
| 04/17/2003 | CA2461824A1 Nucleic acids encoding linked chromo/fluorescent domains and methods for using the same |
| 04/17/2003 | CA2460625A1 Structural and cytoskeleton-associated proteins |
| 04/17/2003 | CA2460480A1 Molecules for disease detection and treatment |
| 04/17/2003 | CA2460476A1 Protein modification and maintenance molecules |
| 04/16/2003 | EP1302104A1 P300 transgenic animal |
| 04/16/2003 | EP1302103A1 Method of culturing zooplankton, apparatus for culturing by the same, and culture obtained by the same |
| 04/16/2003 | EP1301592A2 Recombinant bacterial phytases and uses thereof |
| 04/16/2003 | EP1301590A2 Stem cell-like cells |
| 04/16/2003 | EP1301539A2 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 04/16/2003 | EP0918455B1 Use of galanin to repair nerve damage |
| 04/16/2003 | EP0648271B1 Adenovirus mediated transfer of genes to the gastrointestinal tract |
| 04/16/2003 | EP0591462B1 Universal donor cells |
| 04/16/2003 | CN1411470A Transgenic mice expressing fluorescent protein |
| 04/16/2003 | CN1411378A Method for production of egg containing anti-pathogenic bacteria specific antibodies (IgY) and yogurt and ice cream containing IgY |
| 04/15/2003 | US6548740 Introduction of exogenous nucleotide sequences into a genome by microinjection of infectious retrovirus into the perivitelline space of the egg; making a bovine embryo; use to confer disease resistance, for example |
| 04/15/2003 | US6548739 Method for activating peroxisome proliferator activated receptor-γ |
| 04/15/2003 | US6548736 Transgenic mouse with modified 7B2 gene having a phenotype of at least one of hypoglycemia, hyperproinsulinemia, hypercortisolism, increased plasma ACTH (adrenocorticotrophin) or increased serum corticosterone |
| 04/15/2003 | US6548735 5'-flanking sequence such as beta-lactoglobulin and DNA coding for a serine protease such as alpha1-antitrypsin or a blood factor |
| 04/15/2003 | US6548733 Function-based small molecular weight compound screening system in drosophila melanogaster |
| 04/15/2003 | US6548653 Erythropoietin analog-human serum albumin fusion |
| 04/15/2003 | US6548294 Device for treatment of waste materials with harvester access zone |
| 04/10/2003 | WO2003029912A2 Animal healthcare, well-being and nutrition |
| 04/10/2003 | WO2003029464A2 Genes associated with mast cell activation |
| 04/10/2003 | WO2003029454A2 Non-human animal model for analysis of the origin and therapy of organ fibrosis |
| 04/10/2003 | WO2003029437A2 Secreted proteins |
| 04/10/2003 | WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
| 04/10/2003 | WO2003029412A2 Restricted expression lentivial vectors |
| 04/10/2003 | WO2003028756A2 An in vivo animal model of chronic arterial occlusion and use of collagenase to facilitate guide wire crossing in chronic arterial occlusions |
| 04/10/2003 | WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 04/10/2003 | WO2003028536A2 Methods for diagnosing and treating heart disease |
| 04/10/2003 | WO2003028446A2 An invertebrate animal model with alzheimer-like pathology for screening and testing molecules |
| 04/10/2003 | WO2003028444A1 Nonhuman mammal model of autoimmune disease having ox40l gene transferred thereinto |
| 04/10/2003 | WO2003028443A1 Screening methods for agents that modulate degenerative disorders associated with bcl-2-and bim |
| 04/10/2003 | WO2003017935A9 Human antibodies specific for interleukin 15 (il-15) |
| 04/10/2003 | WO2003005812A3 Modulation of metabolism of steroids and xenobiotics |
| 04/10/2003 | WO2003000861A9 Eukaryotic genes involved in adult lifespan regulation |